Dysregulation of striatal dopamine release in a mouse model of dystonia

Journal of Neurochemistry

Volumn 114, Issue 6, 2010, Pages 1781-1791

  Bao, Li ^a   Patel, Jyoti C ^a   Walker, Ruth H ^b,c   Shashidharan, Pullanipally ^c   Rice, Margaret E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

acetylcholine; basal ganglia; brain slices; early onset dystonia; voltammetry

Indexed keywords

AUTORECEPTOR; CALCIUM; CARBON FIBER; DOPAMINE; MECAMYLAMINE; NICOTINIC RECEPTOR; DOPAMINE 2 RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DYSTONIA; EXTRACELLULAR CALCIUM; HYPERACTIVITY; IN VIVO STUDY; MICROELECTRODE; MOUSE; NONHUMAN; PHENOTYPE; POTENTIOMETRY; PRIORITY JOURNAL; TRANSGENIC MOUSE; AGONISTS; ANIMAL; DISEASE MODEL; DRUG EFFECTS; ELECTROSTIMULATION; GENETICS; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS; MUS MUSCULUS;

ANIMALS; AUTORECEPTORS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DYSTONIA; ELECTRIC STIMULATION; IN VITRO TECHNIQUES; MICE; MICE, TRANSGENIC; NICOTINIC ANTAGONISTS; RECEPTORS, DOPAMINE D2;

EID: 77956322145     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06890.x     Document Type: Article

References (90)

1. Albin R. L., Young A. B. Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366 375.
2. Augood S. J., Penney Jr. J. B., Friberg I. K., Breakefield X. O., Young A. B., Ozelius L. J. Standaert D. G. (1998) Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann. Neurol. 43, 669 673.
3. Augood S. J., Martin D. M., Ozelius L. J., Breakefield X. O., Penney Jr. J. B. Standaert D. G. (1999) Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann. Neurol. 46, 761 769.
4. Augood S. J., Keller-McGandy C. E., Siriani A., Hewett J., Ramesh V., Sapp E., DiFiglia M., Breakefield X. O. Standaert D. G. (2003) Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain. Brain Res. 986, 12 21.
5. 2. J. Neurosci. 23, 2744 2750.
6. Balcioglu A., Kim M. O., Sharma N., Cha J. H., Breakefield X. O. Standaert D. G. (2007) Dopamine release is impaired in a mouse model of DYT1 dystonia. J. Neurochem. 102, 783 788.
7. 2 elevation, not ATP depletion. J. Neurosci. 25, 10029 10040.
8. Benoit-Marand M., Borrelli E. Gonon F. (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21, 9134 9141.
9. Berardelli A., Rothwell J. C., Hallett M., Thompson P. D., Manfredi M. Marsden C. D. (1998) The pathophysiology of primary dystonia. Brain 121, 1195 1212.
10. Bergquist F., Jonason J., Pileblad E. Nissbrandt H. (1998) Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J. Neurochem. 70, 1532 1540.
11. Breakefield X. O., Blood A. J., Li Y., Hallet M., Hanson P. I. Standaert D. G. (2008) The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 9, 222 234.
12. Bressman S. B. (2004) Dystonia genotypes, phenotypes, and classification. Adv. Neurol. 94, 101 107.
13. Bruno M. K., Ravina B., Garraux G. et al. (2004) Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease. Mov. Disord. 19, 228 230.
14. 2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J. Neurosci. 21, 7841 7847.
15. 2+ channels contrasted with strong regulation of axonal dopamine release. J. Neurochem. 96, 645 655.
16. Chiken S., Shashidharan P. Nambu A. (2008) Cortically evoked long-lasting inhibition of pallidal neurons in a transgenic mouse model of dystonia. J. Neurosci. 28, 13967 13977.
17. Cohen L. G. Hallett M. (1988) Hand cramps: clinical features and electromyographic patterns in a focal dystonia. Neurology 38, 1005 1012.
18. Cragg S. J. (2003) Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J. Neurosci. 23, 4378 4385.
19. Dajas-Bailador F. Wonnacott S. (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25, 317 324.
20. Dang M. T., Yokoi F., McNaught K. S., Jengelley T. A., Jackson T., Li J. Li Y. (2005) Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196, 452 463.
21. Dang M. T., Yokoi F., Pence M. A. Li Y. (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 56, 470 474.
22. Dani J. A. Bertrand D. (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47, 699 729.
23. Fabbrini G., Brotchie J. M., Grandas F., Nomoto M. Goetz C. G. (2007) Levodopa-induced dyskinesias. Mov. Disord. 22, 1379 1389.
24. Fahn S. (1983) High dosage anticholinergic therapy in dystonia. Neurology 33, 1255 1261.
25. Fahn S., Bressman S. B. Marsden C. D. (1998) Classification of dystonia. Adv. Neurol. 78, 1 10.
26. Farmer S. F., Sheean G. L., Mayston M. J., Rothwell J. C., Marsden C. D., Conway B. A., Halliday D. M., Rosenberg J. R. Stephens J. A. (1998) Abnormal motor unit synchronization of antagonist muscles underlies pathological co-contraction in upper limb dystonia. Brain 121, 801 814.
27. Goodchild R. E., Kim C. E. Dauer W. T. (2005) Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48, 923 932.
28. Grace A. A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1 24.
29. Grace A. A. Bunney B. S. (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4, 2877 2890.
30. Grundmann K., Reischmann B., Vanhoutte G. et al. (2007) Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 27, 190 206.
31. Hallett M. (1981) Bromocriptine for levodopa-induced end-of-dose dystonia. Lancet 317, 616.
32. Herz E. (1944) Dystonia. 1. Historical review: analysis of dystonic symptoms and physiologic mechanisms involved. Arch. Neurol. Psychiatry 51, 305 318.
33. Hewett J., Johanson P., Sharma N., Standaert D. Balcioglu A. (2010) Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo. J. Neurochem. 113, 228 253.
34. Hyland B. I., Reynolds J. N., Hay J., Perk C. G. Miller R. (2002) Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475 492.
35. Ichinose H., Suzuki T., Inagaki H., Ohye T. Nagatsu T. (1999) Molecular genetics of dopa-responsive dystonia. Biol. Chem. 380, 1355 1364.
36. Jankovic J. (2009) Treatment of hyperkinetic movement disorders. Lancet Neurol. 8, 844 856.
37. 123I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia. Neurology 59, 1974 1976.
38. Kim D. S., Szczypka M. S. Palmiter R. D. (2000) Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J. Neurosci. 20, 4405 4413.
39. Kramer P. L., Ozelius L., Brin M. F., Fahn S., Kidd K. K., Gusella J. Breakefield X. O. (1988) Molecular genetics of an autosomal dominant form of torsion dystonia. Adv. Neurol. 50, 57 66.
40. Kramer P. L., Heiman G. A., Gasser T. et al. (1994) The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am. J. Hum. Genet. 55, 468 475.
41. Li X., Patel J. C., Wang J., Avshalumov M. V., Nicholson C., Buxbaum J. D., Elder G. A., Rice M. E. Yue Z. (2010) Enhanced motor performance and striatal dopamine transmission with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J. Neurosci. 30, 1788 1797.
42. Limberger N., Trout S. J., Kruk Z. L. Starke K. (1991) "Real time" measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 344, 623 629.
43. Liu X., Tailor J., Wang S., Yianni J., Gregory R., Stein J. Aziz T. (2004) Reversal of hypertonic co-contraction after bilateral pallidal stimulation in generalised dystonia: a clinical and electromyogram case study. Mov. Disord. 19, 336 340.
44. Ljungberg T., Apicella P. Schultz W. (1992) Responses of monkey dopamine neurons during learning of behavioral reactions. J. Neurophysiol. 67, 145 163.
45. Marsden C. D. Rothwell J. C. (1987) The physiology of idiopathic dystonia. Can. J. Neurol. Sci. 14, 521 527.
46. Martella G., Tassone A., Sciamanna G. et al. (2009) Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 132, 2336 2349.
47. Mink J. W. (2003) The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch. Neurol. 60, 1365 1368.
48. Misbahuddin A., Placzek M. R., Taanman J. W., Gschmeissner S., Schiavo G., Cooper J. M. Warner T. T. (2005) Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Disord. 20, 432 440.
49. Morris G., Arkadir D., Nevet A., Vaadia E. Bergman H. (2004) Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 43, 133 143.
50. 123I] beta-CIT. Mov. Disord. 13, 319 323.
51. Nausieda P. A., Weiner W. J. Klawans H. L. (1980) Dystonic foot response of Parkinsonism. Arch. Neurol. 37, 132 136.
52. Obeso J. A., Rothwell J. C., Lang A. E. Marsden C. D. (1983) Myoclonic dystonia. Neurology 33, 825 830.
53. Ozelius L. J., Kramer P. L., Moskowitz C. B., Kwiatkowski D. J., Brin M. F., Bressman S. B., Schuback D. E., Falk C. T., Risch N. de Leon D. (1989) Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron 2, 1427 1434.
54. Ozelius L. J., Hewett J., Kramer P. et al. (1997) Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium. Genome Res. 7, 483 494.
55. Page M. E., Bao L., Andre P., Pelta-Heller J., Sluzas E., Gonzalez-Alegre P., Iacovitti L., Rice M. E. Ehrlich M. E. (2010) Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (ΔE) TorsinA in transgenic mice. Neurobiol. Dis. Epub ahead of print doi.
56. Bull D. R., Sheehan M. J., Millar J., Stamford J., Kruk Z. L. Humphrey P. P. A. (1990) Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res. 509, 172-174.
57. Patel J. Rice M. E. (2006) Dopamine release in brain slices, in Encyclopedia of Sensors (Grimes C. A., Dickey E. C. Pishko M. V., eds), Vol. 6, pp. 313 334. American Scientific Publishers, Stevenson Ranch, CA.
58. Patel J., Trout S. J. Kruk Z. L. (1992) Regional differences in evoked dopamine efflux in brain slices of rat anterior and posterior caudate putamen. Naunyn Schmiedebergs Arch. Pharmacol. 346, 267 276.
59. Patel J., Trout S. J., Palij P., Whelpton R. Kruk Z. L. (1995) Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Br. J. Pharmacol. 115, 421 426.
60. Patel J., Mooslehner K. A., Chan P. M., Emson P. C. Stamford J. A. (2003) Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J. Neurochem. 85, 898 910.
61. Patel J. C., Witkovsky P., Avshalumov M. V. Rice M. E. (2009) Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J. Neurosci. 29, 6568 6579.
62. Perlmutter J. S., Tempel L. W., Black K. J., Parkinson D. Todd R. D. (1997a) MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 49, 1432 1438.
63. 18F]spiperone binding in putamen in idiopathic focal dystonia. J. Neurosci. 17, 843 850.
64. Petzinger G. M., Walsh J. P., Akopian G. et al. (2007) Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J. Neurosci. 27, 5291 5300.
65. Phillips P. E. M. Stamford J. A. (2000) Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by 'regular' and 'burst' firing. Brain Res. 884, 139 146.
66. Phillips P. E. M., Hancock P. J. Stamford J. A. (2002) Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 44, 15 22.
67. Pisani A., Martella G., Tscherter A., Bonsi P., Sharma N., Bernardi G. Standaert D. G. (2006) Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 24, 318 325.
68. 18F]dopa uptake in familial idiopathic dystonia. Brain 116, 1191 1199.
69. Rice M. E. Cragg S. J. (2004) Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7, 583 584.
70. Risch N. J., Bressman S. B., deLeon D., Brin M. F., Burke R. E., Greene P. E., Shale H., Claus E. B., Cupples L. A. Fahn S. (1990) Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am. J. Hum. Genet. 46, 533 538.
71. Romo R. Schultz W. (1990) Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. J. Neurophysiol. 63, 592 606.
72. Sato K., Sumi-Ichinose C., Kaji R. et al. (2008) Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc. Natl Acad. Sci. USA 105, 12551 12556.
73. Schultz W. (2002) Getting formal with dopamine and reward. Neuron 36, 241 263.
74. Sesack S. R., Aoki C. Pickel V. M. (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88 106.
75. Sharma N., Baxter M. G., Petravicz J., Bragg D. C., Schienda A., Standaert D. G. Breakefield X. O. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 5351 5355.
76. Shashidharan P., Sandu D., Potla U., Armata I. A., Walker R. H., McNaught K. S., Weisz D., Sreenath T., Brin M. F. Olanow C. W. (2005) Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genet. 14, 125 133.
77. Starr P. A., Rau G. M., Davis V., Marks Jr. W. J., Ostrem J. L., Simmons D., Lindsey N. Turner R. S. (2005) Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque. J. Neurophysiol. 93, 3165 3176.
78. Threlfell S., Clements M. A., Khodai T., Pienaar I. S., Exley R., Wess J. Cragg S. J. (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J. Neurosci. 30, 3398 3408.
79. Torres G. E., Sweeney A. L., Beaulieu J. M., Shashidharan P. Caron M. G. (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant. Proc. Natl Acad. Sci. USA 101, 15650 15655.
80. Trout S. J. Kruk Z. L. (1992) Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors. Br. J. Pharmacol. 106, 452 458.
81. Vitek J. L., Chockkan V., Zhang J. Y., Kaneoke Y., Evatt M., DeLong M. R., Triche S., Mewes K., Hashimoto T. Bakay R. A. (1999) Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann. Neurol. 46, 22 35.
82. Vonsattel J. P. DiFiglia M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369 384.
83. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D. Richardson Jr. E. P. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559 577.
84. Walker R. H., Brin M. F., Sandu D., Gujjari P., Hof P. R., Olanow C. Shashidharan P. (2001) Distribution and immunohistochemical characterization of TorsinA immunoreactivity in rat brain. Brain Res. 900, 348 354.
85. Wichmann T. (2008) Commentary: dopaminergic dysfunction in DYT1 dystonia. Exp. Neurol. 212, 242 246.
86. Yanagisawa N. Goto A. (1971) Dystonia musculorum deformans. Analysis with electromyography. J. Neurol. Sci. 13, 39 65.
87. Zhang H. Sulzer D. (2004) Frequency-dependent modulation of dopamine release by nicotine. Nat. Neurosci. 7, 581 582.
88. Zhao Y., DeCuypere M. LeDoux M. S. (2008) Abnormal motor function and dopamine neurotransmission in DYT1 ΔGAG transgenic mice. Exp. Neurol. 210, 719 730.
89. Zhou F. M., Liang Y. Dani J. A. (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4, 1224 1229.
90. Zhuang P., Li Y. Hallett M. (2004) Neuronal activity in the basal ganglia and thalamus in patients with dystonia. Clin. Neurophysiol. 115, 2542 2557.